The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease.


Journal

Reviews on recent clinical trials
ISSN: 1876-1038
Titre abrégé: Rev Recent Clin Trials
Pays: United Arab Emirates
ID NLM: 101270873

Informations de publication

Date de publication:
2022
Historique:
received: 11 10 2021
revised: 30 12 2021
accepted: 31 01 2022
pubmed: 30 3 2022
medline: 27 10 2022
entrez: 29 3 2022
Statut: ppublish

Résumé

During the COVID-19 pandemic in Italy, decisions were taken to adopt restrictive legislative measures, such as the first half of the 2020 lockdown. In those months, patients with inflammatory bowel disease experienced social isolation and reduced access to health care. We aimed to evaluate, in this condition, the presence of remission subgroups that were most impacted by the lockdown. During the first Italian lockdown, we recruited patients with remission of inflammatory bowel disease by administering an online questionnaire including patient demographics, the Beck Anxiety Questionnaire Inventory, the Beck Depression Inventory questionnaire, and the Pittsburg Sleep Quality Index, all validated standardized questionnaires for anxiety symptom levels, depression, and sleep quality. Our results showed how female patients (p<0.0001) with Crohn's disease (p<0.001) experienced worse levels of anxiety symptoms. Female patients (p<0.0001) between 50 and 60 years of age (p=0.013) with Crohn's disease (p=0.047) experienced worse levels of depressive symptoms. Females also experienced significantly worse sleep levels (p<0.001). We found a correlation between the number of sleeping hours (p<0.001) and the time taken to fall asleep (p<0.001) and the Beck Anxiety Questionnaire Inventory,which showed a linear worsening of the number of minutes it took to fall asleep, and the Beck Depression Inventory questionnaire. Among patients with remission of inflammatory bowel disease, female patients, patients with Crohn's disease, and people aged between 50 and 70 years should be considered for screening for anxiety and depression disorders and an assessment of sleep quality.

Sections du résumé

BACKGROUND
During the COVID-19 pandemic in Italy, decisions were taken to adopt restrictive legislative measures, such as the first half of the 2020 lockdown. In those months, patients with inflammatory bowel disease experienced social isolation and reduced access to health care.
OBJECTIVE
We aimed to evaluate, in this condition, the presence of remission subgroups that were most impacted by the lockdown.
METHODS
During the first Italian lockdown, we recruited patients with remission of inflammatory bowel disease by administering an online questionnaire including patient demographics, the Beck Anxiety Questionnaire Inventory, the Beck Depression Inventory questionnaire, and the Pittsburg Sleep Quality Index, all validated standardized questionnaires for anxiety symptom levels, depression, and sleep quality.
RESULTS
Our results showed how female patients (p<0.0001) with Crohn's disease (p<0.001) experienced worse levels of anxiety symptoms. Female patients (p<0.0001) between 50 and 60 years of age (p=0.013) with Crohn's disease (p=0.047) experienced worse levels of depressive symptoms. Females also experienced significantly worse sleep levels (p<0.001). We found a correlation between the number of sleeping hours (p<0.001) and the time taken to fall asleep (p<0.001) and the Beck Anxiety Questionnaire Inventory,which showed a linear worsening of the number of minutes it took to fall asleep, and the Beck Depression Inventory questionnaire.
CONCLUSION
Among patients with remission of inflammatory bowel disease, female patients, patients with Crohn's disease, and people aged between 50 and 70 years should be considered for screening for anxiety and depression disorders and an assessment of sleep quality.

Identifiants

pubmed: 35346015
pii: RRCT-EPUB-121933
doi: 10.2174/1574887117666220328125720
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109-119

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Annamaria Spina (A)

Department of Precision Medicine, Hepatogastroenterology Unit, University of Campania "Luigi Vanvitelli", via Pansini, 5, Naples, 80138, Italy.

Chiara Mazzarella (C)

Department of Precision Medicine, Hepatogastroenterology Unit, University of Campania "Luigi Vanvitelli", via Pansini, 5, Naples, 80138, Italy.

Marcello Dallio (M)

Department of Precision Medicine, Hepatogastroenterology Unit, University of Campania "Luigi Vanvitelli", via Pansini, 5, Naples, 80138, Italy.

Mario Romeo (M)

Department of Precision Medicine, Hepatogastroenterology Unit, University of Campania "Luigi Vanvitelli", via Pansini, 5, Naples, 80138, Italy.

Raffaele Pellegrino (R)

Department of Precision Medicine, Hepatogastroenterology Unit, University of Campania "Luigi Vanvitelli", via Pansini, 5, Naples, 80138, Italy.

Tommaso Durante (T)

Mental Health Department, S. Pio Hospital, via dell'Angelo, Benevento, 82100, Italy.

Marco Romano (M)

Department of Precision Medicine, Hepatogastroenterology Unit, University of Campania "Luigi Vanvitelli", via Pansini, 5, Naples, 80138, Italy.

Carmelina Loguercio (C)

Department of Precision Medicine, Hepatogastroenterology Unit, University of Campania "Luigi Vanvitelli", via Pansini, 5, Naples, 80138, Italy.

Maurizio Di Mauro (M)

Director-General, Azienda Ospedaliera dei Colli, via Leonardo Bianchi, 80131, Naples, Italy.

Alessandro Federico (A)

Department of Precision Medicine, Hepatogastroenterology Unit, University of Campania "Luigi Vanvitelli", via Pansini, 5, Naples, 80138, Italy.

Antonietta Gerarda Gravina (AG)

Department of Precision Medicine, Hepatogastroenterology Unit, University of Campania "Luigi Vanvitelli", via Pansini, 5, Naples, 80138, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH